IVA CONDE: Open Payments
NPI 1831212943 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,544 in 35 payments from 10 companies in 2025. Trend: 2023 $437 · 2024 $818 · 2025 $3,544
Speaker / faculty: $3,000Food & beverage: $509Travel & lodging: $35
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $3,207 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Alkermes, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 2 | $28 |
| Corium, LLC | 1 | $21 |
| Indivior Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, COBENFY, CAPLYTA, INGREZZA, Auvelity, ARISTADA, FANAPT.
Industry payments across LA — which companies pay providers there.
